Browse All

Current Filters

CLEAR FILTER x

TITLE

Assessing Safety of High-efficacy Multiple Sclerosis Therapies in Elderly Patients

Author:Varela, Lucia Belen   Casales, Federico   Burbano Donoso, Claudia   Heriz, Alejandra   Gonzalez, Cecilia   Miguez, Jimena   Alonso, Ricardo   Silva, Berenice   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.013  

Author Institution:Italian Hospital of Buenos Aires, Buenos Aires, Argentina  Centro Universitario de Esclerosis Múltiple (CUEM) Hospital Ramos Mejía, Buenos Aires, Argentina  

Risk Factors for Peripartum Mood Disorders in Women with MS: A Prospective Study

Author:Rose, Madeleine   Hsu, Stephanie   Balan, Ayushi   Anderson, Annika   Houtchens, Maria   Bove, Riley   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.014  

Author Institution:University of California, San Francisco, San Francisco, CA  Harvard Medical School , Boston, MA  University of California, San Francisco, Berkeley, CA  

Safety of Discontinuing Disease-modifying Therapy in Aging MS Patients: A Single-center Study

Author:Polonski, Cori   Wong, Ka-Ho   Francis, Trieste   Rose, John   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.015  

Author Institution:University of Utah, Salt Lake City, UT  U of U Neurology Clinic, Salt Lake City, UT  Imaging and Neurosciences Center, Salt Lake City, UT  

Multiple Sclerosis in a Patient with Friedreich's Ataxia

Author:Yu, Yang   Kushlaf, Hani   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.016  

Author Institution:University of Cincinnati, Cincinnati, OH  

Effectiveness and Safety of High-efficacy Disease-modifying Therapy in Pediatric Multiple Sclerosis: A Retrospective Analysis at a Single Center

Author:Walsh, Rachel   Van Haren, Keith   

Session Name:P4: Multiple Sclerosis: Special Populations  

Topic:Multiple Sclerosis  

Program Number:P4.017  

Author Institution:Neurology at Stanford University, Palo alto, CA